Clinical Outcome Endpoints in Heart Failure Trials: A European Society of Cardiology Heart Failure Association Consensus Document
Faı̈ez Zannad(Centre d’Investigation Clinique Innovation Technologique de Nancy), John J.V. McMurray(University of Glasgow), Inger Ekman(Sahlgrenska University Hospital), Burkert Pieske(Berlin Institute of Health at Charité - Universitätsmedizin Berlin), Thomas Severin(Novartis (Switzerland)), Adrian F. Hernandez(Duke University), Frank Ruschitzka(Kantonsspital St. Gallen), Ángeles García(European Medicines Agency), Holger Woehrle(ResMed (United States)), John G.F. Cleland(University of Glasgow), Piotr Ponikowski(Wroclaw Medical University), Jay N. Cohn(University of Minnesota), Gerasimos Filippatos(National and Kapodistrian University of Athens), Stuart Pocock(London School of Hygiene & Tropical Medicine), Paul W. Armstrong(Canadian VIGOUR Centre), Wendy Gattis Stough(Campbell University), Gonzalo Calvo(Hospital Clínic de Barcelona), Luigi Tavazzi(Maria Cecilia Hospital), Luís M. Ruilope(Bayer (Germany)), Ileana L. Piña(American Heart Association), Tiny Jaarsma(Linköping University), Joerg Koglin(Ludwig-Maximilians-Universität München), Marvin A. Konstam(Tufts Medical Center), Marco Metra(Vita-Salute San Raffaele University), Scott D. Solomon(Brigham and Women's Hospital), Stuart Kupfer(Cytokinetics (United States)), Giuseppe Rosano(St George's Hospital), Adriaan A. Voors(University Medical Center Groningen), Alexandre Mebazaa(Marqueurs cardiovasculaires en situation de stress), Karl Swedberg(Brigham and Women's Hospital), Scott M. Wasserman(Amgen (United States)), Aldo P. Maggioni(Health Care Foundation), Kenneth Dickstein, Andrew Zalewski(Novartis (United States)), Michaël Domanski(Mount Sinai Hospital), Kenneth M. Steín(Boston Scientific (United States)), Mihai Gheorghiade(Northwestern University), Christina Nowack(Berlin Institute of Health at Charité - Universitätsmedizin Berlin), Norman Stockbridge(United States Food and Drug Administration), Stefan D. Anker(Bayer (Germany))
Cited by 233
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
Recommendations for Chamber Quantification: A Report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, Developed in Conjunction with the European Association of Echocardiography, a Branch of the European Society of Cardiology
|Journal of the American Society of Echocardiography|2005|11.3k
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
|New England Journal of Medicine|1999|9.1k
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k